Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) shares saw strong trading volume on Monday. 112,449 shares traded hands during trading, an increase of 48% from the average daily volume of 76,050 shares. The stock last traded at $4.1780 and had previously closed at $3.89.
Wall Street Analyst Weigh In
Separately, Weiss Ratings upgraded Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, October 8th. One equities research analyst has rated the stock with a Hold rating. Based on data from MarketBeat.com, Anbio Biotechnology currently has an average rating of “Hold”.
View Our Latest Report on NNNN
Anbio Biotechnology Stock Down 6.9%
The stock’s fifty day moving average price is $4.93 and its 200-day moving average price is $16.27.
About Anbio Biotechnology
Anbio Biotechnology is a medical technology company focused on in vitro diagnostic products used to detect and monitor health conditions. Its offerings include diagnostic testing systems and related products designed for clinical and point-of-care settings. The company’s product portfolio includes testing equipment and diagnostic reagents, supporting the analysis of patient samples. These tools are intended to help healthcare providers obtain test results outside or alongside conventional laboratory workflows.
Further Reading
- Five stocks we like better than Anbio Biotechnology
- The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom
- 3 Insider Selling Stories; 3 Different Signals for Investors
- The Trade Desk Beats on Revenue, But the Fine Print Matters
- Poll Reveals: Which States Are Most Prepared for a Crisis? [2026]
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
